Analyst Information


Edward Tenthoff

Sr Research Analyst

Edward Tenthoff

Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania.

Universe Coverage:
Healthcare:   Biotechnology, Medical Diagnostics
AGLEAeglea Biotherapeutics, Inc.
ALNYAlnylam Pharmaceuticals, Inc.
ALPNAlpine Immune Sciences, Inc.
APVOAptevo Therapeutics Inc.
ARAVAravive, Inc.
ARGXargenx SE
ARWRArrowhead Pharmaceuticals
ARVNArvinas Inc.
ASLNAslan Pharmaceuticals Ltd.
BCYCBicycle Therapeutics Ltd.
CCXIChemoCentryx, Inc.
CHMAChiasma, Inc.
CRSPCRISPR Therapeutics AG
CYTKCytokinetics, Incorporated
DYNDyne Therapeutics, Inc.
ELOXEloxx Pharmaceuticals, Inc.
EXELExelixis, Inc.
FATEFate Therapeutics, Inc.
FULCFulcrum Therapeutics, Inc.
GMDAGamida Cell Ltd.
IGMSIGM Biosciences, Inc.
KDS NAKiadis Pharma NV
MISTMilestone Pharmaceuticals, Inc.
MRNAModerna, Inc.
NXTCNextCure, Inc.
OPKOPKO Health, Inc.
PROGProgenity, Inc.
PTIProteostasis Therapeutics, Inc.
MCRBSeres Therapeutics, Inc.
STROSutro Biopharma, Inc.
SYBXSynlogic, Inc.
SYRSSyros Pharmaceuticals, Inc.
VRTXVertex Pharmaceuticals Inc.
XNCRXencor, Inc.